Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

Apoptotic Myeloid Marker Inhibitors

Apoptotic Myeloid Marker Inhibitors are a class of compounds that specifically interfere with the signaling pathways and molecular mechanisms involved in the regulation of apoptosis in myeloid cells. Apoptosis, or programmed cell death, is a crucial process that ensures cellular turnover, the removal of damaged cells, and the maintenance of tissue homeostasis. Myeloid cells, which include various types of white blood cells such as granulocytes, monocytes, and macrophages, are essential components of the immune system. They play a pivotal role in responding to infections and other pathological stimuli. However, the over-activation or inappropriate inhibition of apoptotic pathways in myeloid cells can lead to a variety of pathological conditions. Apoptotic Myeloid Marker Inhibitors function by targeting specific proteins or enzymes that are critical for the initiation or execution of apoptosis in these cells. This interference with the apoptotic machinery alters the survival and function of myeloid cells, which can have significant implications for their role in immune responses and other biological processes. These inhibitors typically target key regulators of apoptosis such as Bcl-2 family proteins, caspases, or death receptors, which are often aberrantly expressed or activated in myeloid cells under certain conditions. By binding to these targets, Apoptotic Myeloid Marker Inhibitors can prevent the activation of downstream apoptotic pathways, leading to the stabilization of myeloid cell populations and the modulation of their activity. The development and characterization of these inhibitors involve extensive biochemical and structural studies to determine their specificity, binding affinity, and effects on cellular signaling networks. Moreover, understanding the precise molecular interactions and structural dynamics involved in the inhibition process is critical for optimizing the efficacy and selectivity of these compounds. This class of inhibitors not only provides insight into the intricate regulation of apoptosis in myeloid cells but also serves as valuable tools for studying the broader implications of apoptosis in immune system function and cell biology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Q-VD-OPH

1135695-98-5sc-222230
5 mg
$782.00
5
(1)

By preventing caspase activation, Q-VD-OPh could stall the apoptotic process, resulting in decreased presence of apoptotic markers in myeloid cells.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Imatinib might suppress the tyrosine kinase-mediated signaling cascade, leading to a decreased transcriptional activity of genes encoding apoptotic markers in myeloid cells.

ABT 737

852808-04-9sc-207242
2.5 mg
$200.00
54
(3)

ABT-737 may lead to increased apoptosis of myeloid cells by antagonizing anti-apoptotic proteins, but paradoxically, this could result in a short-term decrease in apoptotic marker presence as cells are rapidly cleared.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$56.00
$256.00
113
(3)

By inhibiting autophagy, 3-Methyladenine could prevent the degradation of intracellular components, including apoptotic markers, thus maintaining their levels in myeloid cells.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Thalidomide can downregulate the expression of TNF-α, potentially leading to a decreased stimulus for apoptosis and thus lower levels of apoptotic markers in myeloid cells.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin may downregulate the expression of genes involved in apoptosis by inhibiting the transcription factor NF-κB, resulting in decreased levels of apoptotic markers in myeloid cells.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As a JNK pathway inhibitor, SP600125 could reduce the stress-induced apoptotic response, consequently decreasing the levels of apoptotic markers in myeloid cells.

caspase-9 inhibitor I

210345-04-3sc-3085
sc-3085A
1 mg
5 mg
$408.00
$1734.00
33
(0)

Z-LEHD-FMK may prevent the mitochondrial pathway of apoptosis by inhibiting caspase-9 activation, which could result in reduced cleavage of apoptotic markers in myeloid cells.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059, by inhibiting MEK1/2, might lower ERK pathway signaling, leading to diminished transcriptional activation of genes related to apoptosis and thereby lower expression of apoptotic markers in myeloid cells.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 might decrease the activation of the PI3K/Akt pathway, which is known to promote cell survival, potentially resulting in downregulated expression of survival signals and increased expression of apoptotic markers in myeloid cells.